QDEL
Quidelortho Corp

3,552
Mkt Cap
$1.98B
Volume
716,688.00
52W High
$43.92
52W Low
$19.50
PE Ratio
-1.71
QDEL Fundamentals
Price
$29.26
Prev Close
$29.10
Open
$29.21
50D MA
$29.43
Beta
1.23
Avg. Volume
1.06M
EPS (Annual)
-$30.54
P/B
0.97
Rev/Employee
$422,030.30
Loading...
Loading...
News
all
press releases
QuidelOrtho Corporation $QDEL Shares Purchased by Allianz Asset Management GmbH
Allianz Asset Management GmbH grew its position in shares of QuidelOrtho Corporation (NASDAQ:QDEL - Free Report) by 98.6% during the 3rd quarter, according to its most recent filing with the...
MarketBeat·2d ago
News Placeholder
More News
News Placeholder
Earnings Preview: QuidelOrtho (QDEL) Q4 Earnings Expected to Decline
QuidelOrtho (QDEL) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Zacks·6d ago
News Placeholder
QuidelOrtho Receives Excellence Services Label in EMEA and Two Stevie Awards
QuidelOrtho Receives Excellence Services Label in EMEA and Two Stevie Awards QuidelOrtho Receives Excellence Services Label in EMEA and Two Stevie Awards PR Newswire SAN DIEGO, Feb. 3, 2026 First...
PR Newswire·7d ago
News Placeholder
Gagnon Securities LLC Grows Stock Holdings in QuidelOrtho Corporation $QDEL
Gagnon Securities LLC raised its stake in shares of QuidelOrtho Corporation (NASDAQ:QDEL - Free Report) by 68.1% in the 3rd quarter, according to the company in its most recent filing with the...
MarketBeat·11d ago
News Placeholder
QuidelOrtho (NASDAQ:QDEL) Shares Down 7.9% - Time to Sell?
QuidelOrtho (NASDAQ:QDEL) Trading Down 7.9% - Here's What Happened...
MarketBeat·17d ago
News Placeholder
Strengthening the blood supply: Awareness, challenges and donor impact
Strengthening the blood supply: Awareness, challenges and donor impact Strengthening the blood supply: Awareness, challenges and donor impact PR Newswire SAN DIEGO, Jan. 22, 2026 SAN DIEGO, Jan. 22...
PR Newswire·19d ago
News Placeholder
QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results
QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results QuidelOrtho to Report Fourth Quarter and Full-Year 2025 Financial Results PR Newswire SAN DIEGO, Jan. 21, 2026 SAN DIEGO...
PR Newswire·20d ago
News Placeholder
QuidelOrtho (NASDAQ:QDEL) Stock Price Down 6% - Here's Why
QuidelOrtho (NASDAQ:QDEL) Trading Down 6% - Time to Sell...
MarketBeat·24d ago
News Placeholder
Reasons to Retain QuidelOrtho Stock in Your Portfolio for Now
QDEL's decent Q3 2025 results and expanding diagnostics portfolio support near-term growth despite respiratory reliance and payer risks.
Zacks·26d ago
News Placeholder
QuidelOrtho (NASDAQ:QDEL) Upgraded by Zacks Research to Hold Rating
Zacks Research upgraded shares of QuidelOrtho from a "strong sell" rating to a "hold" rating in a research report on Tuesday...
MarketBeat·26d ago
<
1
2
...
>

Latest QDEL News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.